Abstract
Human adipocytes express high levels of two distinct lipid droplet proteins, Fat Specific Protein 27 (FSP27; also called CIDEC), a member of the CIDE family, and perilipin1 (PLIN1), a member of the PAT family. Both proteins play a role in fat metabolism in adipocytes, but how they interact is not known. Our present study demonstrates that FSP27 and PLIN1 co-localize and interact in cultured human primary adipocytes. We also found that the C-terminal domain of FSP27, aa 120–220, interacts with PLIN1. Individual expression of exogenous FSP27 or PLIN1 increased triglyceride content and decreased glycerol release (a measure of lipolysis), but co-expression of both proteins did not further increase triglyceride content or decrease lipolysis in human adipocytes. However, the combination of PLIN1 and FSP27 increased the average size of lipid droplets or caused the formation of unilocular adipocytes. Our data suggest that FSP27 interacts with PLIN1 to regulate lipid droplet size in human adipocytes in a concerted manner.
Keywords: Adipocytes, fat metabolism, fatty acids, glycerol, fat, lipolysis
1. Introduction
Cellular lipid droplets (LDs), now considered to be dynamic intracellular organelles, are composed of a core of neutral lipids surrounded by a phospholipid monolayer and associated proteins [1; 2; 3; 4; 5]. Proteins associated with the surface of LDs contribute to the biogenesis, maturation and stability of these organelles [1; 6]. Of the LD-associated proteins, the best-characterized are members of the PAT family, also called the perilipin (Plin) family of proteins [7; 8; 9; 10; 11]. They act as a scaffold at the LD surface and are suggested to have a structural and/or regulatory role in LD formation and function [8; 10; 12].
PLIN1 (also called Perilipin1) is highly expressed in adipocytes and plays a crucial role in regulating basal and stimulated lipolysis [8; 13]. Under basal conditions, PLIN1 prevents excess lipolysis by limiting access of hormone sensitive lipase, ATGL and its co-activator CGI-58 to LDs [14; 15; 16; 17; 18]. Upon β-adrenergic stimulation, protein kinase A (PKA) phosphorylates PLIN1 and causes the release of CGI-58 so it can bind and stimulate ATGL and also allows HSL to translocate to the LD surface [18; 19]. PLIN1 knockout increases basal lipolysis and decreases LD size in adipocytes and causes resistance to diet induced obesity in mice [20; 21]. In humans, lower PLIN1 expression is associated with higher rates of lipolysis [21; 22], and mutation in PLIN1 [23; 24], or its expression in obese human adipose tissue [25], correlates positively with insulin sensitivity.
FSP27 (also called CIDEC in humans) is also abundantly expressed on the LD surface [26; 27; 28] and has been shown to be crucial for the fusion of smaller LDs into larger ones [29; 30] and to promote triglyceride (TG) accumulation [26; 27; 28; 31; 32]. A mutation in CIDEC results in multilocular adipocytes associated with partial lipodystrophy and insulin resistance in a human subject [33]. Also, CIDEC expression was higher in visceral fat from insulin sensitive compared to insulin resistant obese humans [25]. These studies suggest that FSP27 plays an important role in regulating LD morphology and fat metabolism in adipocytes.
In 3T3-L1 adipocytes, exogenously expressed FSP27 co-localizes with endogenous PLIN1 at the LD surface [27]. However, the interaction of these proteins and its consequences for LD morphology and TG accumulation have not yet been reported. In the present study we analyzed the distribution of endogenous FSP27 and PLIN1 in cultured human primary adipocytes and tested the possibility that PLIN1 and FSP27 interact with each other. Furthermore, we analyzed the role of their interaction in regulating the LD morphology and TG accumulation in human adipocytes.
2. Materials and Methods
2.1. Materials
All chemicals were purchased from Sigma (St Louis, MO), except Rosiglitazone (Merck, Rahway, NJ), recombinant human insulin (Lilly, Indianapolis, IN), HCS LipidTOX-Deep Red (Invitrogen, CA). Fetal bovine serum and culture media were obtained from Invitrogen (Carlsbad, CA).
2.2. Cell culture
Human primary preadipocytes, procured from the Boston Nutrition Obesity Research Center adipocyte core, were cultured and differentiated as previously described [34].
2.3. Immunostaining
For determination of PLIN1 and FSP27 localization, cells were cultured on coverslips. The immunostaining was performed using guinea pig anti-perilipin polyclonal antibody (1:1000 dilution; Research Diagnostics Inc., Flanders, NJ) and FSP27 monoclonal antibodies (1:1000 dilution) as described [27].
2.4. Lentivirus production and transduction
293T cells were seeded in 10 cm plates. Recombinant lentiviruses were produced by a five-plasmid transfection procedure as described [35]. The packaged recombinant lentiviruses were harvested from the supernatant of cell cultures 48 h after transfection and filtered through 0.45-μm filters. 500 μl supernatant and 10 μg/ml Polybrene was added to each well of a 12 well plate containing differentiated human adipocytes; after overnight incubation, the medium was changed to a regular maintenance medium. Protein expression was observed after 4 days of transduction.
2.5. Adenovirus transduction
PLIN1-Flag tagged and FSP27-HA tagged adenoviruses were generated at the Adenoviral Vector Core Facility at Tufts Medical Center. Virus was added at m.o.i of 100 to the human adipocytes. Cells were analyzed for protein expression after 24 or 48 h of infection.
2.6. Immunoprecipitation
Fully differentiated human adipocytes in 10 cm plates were transduced with recombinant adenovirus or lentivirus. Immunoprecipitations were carried out using antibodies as we described previously [36].
2.7. Lipid droplet staining
Cells plated on glass cover slips were washed twice with PBS, fixed in 4% formaldehyde for 20 minutes and quenched with 0.1 M glycine. Cells were then incubated with 0.5 μg/ml of Nile Red or HCS LipidTOX-Deep Red stain for 30 minutes and then washed with PBS.
2.8. Microscopy
Microscopy was performed using a Zeiss LSM 710-Live Duo scan (Carl Zeiss, Oberkochen, Germany) with a 100X oil immersion objective. Images were processed using Metamorph imaging software, version 6.1 (Universal Imaging, Downingtown, PA).
2.9. Lipolysis and Triglyceride Determination
The cultured adipocytes were washed twice with PBS and incubated in Krebs-Ringer bicarbonate HEPES buffer supplemented with 4% bovine serum albumin. The buffer was collected after 2.5 hr of incubation for assaying glycerol as a measure of lipolysis. For triglyceride measurement the cells were lysed with cell lysis buffer (CellSignal). Glycerol and triglyceride were quantified using the Triglyceride Determination Kit (Sigma) according to the manufacturer’s instructions.
3. Results
3.1. FSP27 co-localizes with PLIN1 in human adipocytes
Our previous study showed that exogenously expressed GFP-FSP27 co-localizes with endogenous PLIN1 in 3T3-L1 adipocytes [27]. Whether endogenous FSP27 and PLIN1 co-localize is not yet known. Therefore, in the present study the distribution of endogenous proteins was studied by immunofluorescence using monoclonal anti-FSP27 and polyclonal anti-perilipin antibodies. Fig. 1A shows localization of endogenous FSP27 and PLIN1 on the surface of a single LD in a cultured human adipocyte. Although FSP27 and PLIN1 did not completely overlap, the distribution pattern suggested that the two proteins might be in the same complex at the surface of the LD. Interestingly, both FSP27 and PLIN1 were also distributed apart from LDs (Fig. 1B). It could be that besides LDs these proteins are present in the endoplasmic reticulum or on minute LDs. In fact, recent studies have shown that FSP27 [37] and PLIN1 (Skinner et al. Adipocyte Journal (in press)) also localize to the endoplasmic reticulum in adipocytes.
Figure 1. FSP27 and PLIN1 co-localize and co-immunoprecipitate in human adipocytes.

(A) A single LD in a human adipocyte showing the distribution of endogenous FSP27 (green) and PLIN1 (red) at its surface. Nucleus was stained with DAPI (blue). Bar, 10 μm. (B) 4-μm confocal Z-section of a human adipocyte showing localization of endogenous FSP27 (green) and PLIN1 (red). Bar, 10 μm. (C) HA-FSP27 was immunoprecipitated with anti-HA antibodies and immunoblotted with PLIN1 and HA antibodies. (D) Flag-PLIN1 was immunoprecipitated with Flag antibodies and immunoblotted with FSP27 or Flag antibodies. (E) Endogenous PLIN1 was immunoprecipitated with PLIN1 antibodies and immunoblotted with PLIN1 and FSP27 antibodies. (F) HA tagged FSP27(120–220) was immunoprecipitated with HA-antibodies and immunoblotted with PLIN1 or HA antibodies. In panels C, D, E and F, input represents whole cell lysate and control represents the beads conjugated with Flag or HA antibodies which were incubated with the uninfected human adipocytes.
3.2. FSP27 interacts with PLIN1
Based upon the distribution pattern of endogenous FSP27 and PLIN1, we hypothesized that these proteins might interact with each other. To study their interaction, PLIN1-Flag and FSP27-HA constructs were used to produce lenti-viral preparations and infect mature human adipocytes. Anti-Flag and anti-HA antibodies were used to pull down the proteins. As shown in Fig. 1(C–D), endogenous PLIN1 co-immunoprecipitated with FSP27-HA (Fig. 1C) and PLIN1-Flag co-immunoprecipitated endogenous FSP27 (Fig. 1D) in human adipocytes. We therefore could pull down PLIN1 with FSP27 and vice versa. In order to confirm that endogenous PLIN1 and endogenous FSP27 interact with each other, we immunoprecipitated PLIN1 using PLIN1 antibodies and immunoblotted for FSP27. As expected, endogenous FSP27 co-immunoprecipitated with endogenous PLIN1 in human adipocytes (Fig. 1E).
To identify the domain of FSP27 interacting with PLIN1, we first tested if either the N- or C-terminus of FSP27 could pull down PLIN1. HA tagged aa 1–120 (N-terminus) and aa 120–239 (C-terminus) were co-expressed with PLIN1 in COS7 cells, which do not have endogenous expression of FSP27 or PLIN1. HA antibodies were used for immunoprecipitation. Only the C-terminal domain co-immunoprecipitated PLIN1 (data not shown), suggesting that C-terminus of FSP27 is responsible for its interaction with PLIN1. In a recent study we showed that amino acids 173–220 of FSP27 target its localization to LDs and play a role in LD clustering, whereas a fusogenic domain of FSP27 (aa 120–210) is sufficient for both clustering and LD fusion [29]. Therefore, we tested the domain aa 120–220, which spans both functional domains of FSP27 and belongs to the C-terminus region, for its interaction with PLIN1. HA-FSP27(120–220) was expressed in human adipocytes using a lentivirus. HA antibodies were used to immunoprecipitate FSP27. As shown in Fig. 1F, endogenous PLIN1 co-immunoprecipitated with FSP27(120–220), showing that at least aa 120–220 of FSP27 are involved in its interaction with PLIN1.
3.3. Effect of exogenous FSP27 and PLIN1 co-expression on triglyceride accumulation and lipolysis in human adipocytes
Overexpression of FSP27 or PLIN1 in adipocytes enhances TG storage [26; 27; 38], whereas FSP27 or PLIN1 depletion increases basal lipolysis in adipocytes [27; 38; 39; 40]. Therefore, in order to test if FSP27 and PLIN1 have additive or synergistic effect on TG accumulation or lipolysis in human adipocytes, we first examined expression levels of FSP27 and PLIN1 after adenoviral transfection of cultured human adipocytes. As shown in Fig. 2A, there was a 3- to 4-fold increase in the expression of both proteins. We then measured glycerol release into the medium, as a measure of lipolysis, and total TG in the cells. As shown in Fig. 2B, 48 hr after adenoviral-mediated overexpression of FSP27 or PLIN1 in human adipocytes, the total TG amount increased by about 40% and 70 %, respectively, but there was no significant further increase in total TG after 48 hrs of FSP27 and PLIN1 co-overexpression. Similar results were obtained after 72 hr of overexpressing FSP27 and/or PLIN1, that is, no difference in lipolysis or TG after co-overexpressing exogenous FSP27 and PLIN1 compared to the individually overexpressed proteins (data not shown). Consistent with this observation, FSP27 and PLIN1 individually decreased the accumulation of glycerol in the medium by about 30% and 60%, respectively (Fig. 2C). However, there was no additional effect of FSP27 and PLIN1 co-overexpression on glycerol release.
Figure 2. Expressing exogenous FSP27 or PLIN1 increases total TG content while decreasing lipolysis in human adipocytes, but FSP27+PLIN1 has no additional effect on TG content or lipolysis.

(A) Adenovirus-mediated expression of HA-FSP27 and Flag-PLIN1 in human adipocytes using FSP27 and PLIN1 antibodies, respectively. GFP-containing adenovirus was used as a control. (B, C) Biochemical quantification of total triglyceride (B) and lipolysis (C) in human adipocytes infected with control, FSP27, PLIN and FSP27+PLIN1 adenoviruses; *, p<0.05 (paired t-test). Control represents GFP-containing empty virus. For lipolysis, glycerol released in 2.5 h was measured and normalized to total triglycerides and total proteins. The data show an average of three independent experiments. Values are means ± standard error.
3.4. Effect of FSP27 and PLIN1 co-overexpression on lipid droplet size in adipocytes
FSP27 knockdown causes fragmentation of LDs in adipocytes [27; 40]. Also, we and others recently demonstrated the role of FSP27 in regulating LD morphology [29; 30]. Therefore, we hypothesized that FSP27-PLIN1 interaction might facilitate the increase in LD size in human adipocytes. To test our hypothesis, we infected mature human adipocytes with FSP27 and/or PLIN1 adenovirus and studied the LD morphology. At 48–72 h after infection almost 25% of the FSP27 and PLIN1 co-expressing adipocytes showed unilocular droplets (Fig. 3A). Other cells showed either enlarged multiple droplets with tiny droplets surrounding them, or a much enlarged single droplet with almost 3–4 times the average radius of other droplets. A similar increase in LD size was observed when the PLIN1 interacting domain of FSP27, aa 120–220, was co-expressed with PLIN1 (data not shown). Quantitatively, the range of LD size was increased (Fig. 3B) in agreement with the average decrease in number of LDs (Fig. 3C) in adipocytes transduced with FSP27, PLIN1 or FSP27+PLIN1, with a larger effect in FSP27+PLIN1. These results suggest that both FSP27 and PLIN1 regulate the morphology of LDs in a concerted manner.
Figure 3. Transducing FSP27+PLIN1 for 72 hr induces formation of unilocular LDs in cultured human adipocytes.
(A) Phase contrast image showing LD morphology after 72 h of transduction of FSP27, PLIN1 or FSP27+PLIN1 adenoviruses in cultured human adipocytes. Control represents GFP-containing empty virus. Bar, 10 μm. (B) Range of the LD size. (C) Average number of LDs per cell. LD size and number was measured in more than 15 cells in each condition from three independent experiments. Values are means ± standard deviation. *, p≤0.01; **, p≤0.05 (paired t-test).
4. Discussion
We here highlight the role of FSP27-PLIN1 interaction in regulating LD morphology in human adipocytes. We established that endogenous FSP27 and PLIN1 co-localize at the surface of LD in human adipocytes. Co-IP studies showed that these two proteins interact either directly or indirectly. Furthermore, we identified that the C-terminus domain, aa 120–220, of FSP27 interacts with PLIN1. The ability of FSP27 to increase LD size is further enhanced by PLIN1. After 48–72 h of co-expressing FSP27 and PLIN1 in cultured human adipocytes, unilocular LDs were formed in at least 25% of the cells. This morphological change was not associated with further accumulation of TG or a further decline in lipolysis when compared to the individually expressed proteins.
Our recent study identified the LD fusogenic potential of FSP27 [29]. Although direct evidence is lacking, it is likely that PLIN1 acts as a scaffold for FSP27 at the LD surface where FSP27 facilitates the fusion of LDs. A similar study from another group showed that exogenously expressed FSP27 concentrates at the contact site of droplets and promotes LD growth by lipid transfer between the droplets [30], whereas in our studies we did not observe a distinct distribution of endogenous FSP27 or PLIN1 at the contact site of droplets in human adipocytes (Fig. 1B). Probably a more complex process of membrane dynamics than simply a lipid transfer between droplets is involved in their fusion. Proteins like SNARE’s, which have been shown to mediate fusion between cytosolic LDs, could be involved in this integrated process [41]. Further studies are required to establish a mechanism of LD fusion in adipocytes. Our present study suggests a concerted action of FSP27 and PLIN1 in promoting the enlargement of LDs. The expression of exogenous FSP27 in COS7 cells, which do not express endogenous FSP27 or PLIN1, increases LD size [29]. These enlarged droplets in COS7 cells are much smaller than the droplets in adipocytes, suggesting that the presence of both PLIN1 and FSP27 is required for the formation of enlarged LDs in adipocytes. Our observations are further supported by in vivo studies showing that FSP27 knockout mice have multilocular white adipocytes [31; 32; 42], and a mutation in human FSP27 (CIDEC) also mimics the multilocular phenotype in white adipose tissue [33].
It is commonly believed that the decrease in relative surface area on increasing LD size decreases the access of lipases and thus decreases lipolysis. While both PLIN1 and FSP27 overexpression increased triglyceride accumulation, PLIN1 overexpression increased triglyceride accumulation to a greater extent than FSP27. However, co-expression of both proteins had no additional effect on triglyceride content and lipolysis as compared to PLIN1 despite causing formation of larger and in many cases unilocular LDs. This strongly suggests that inhibition of lipolysis is a direct function of these LD surface proteins themselves and not an indirect result of the change in LD morphology, though clearly these two proteins also have important and synergistic roles in controlling LD morphology in adipocytes.
Highlights.
FSP27 interacts with PLIN1, and aa 120–220 of FSP27 play a role in this interaction.
FSP27 and PLIN1 co-localize at the lipid droplet surface in human adipocytes.
FSP27 and PLIN1 interaction regulates lipid droplet morphology.
This study reveals important players in lipid droplet dynamics in adipocytes.
Acknowledgments
We gratefully acknowledge Drs. Keith Tornheim and Vishva Sharma for critically reading the manuscript. This work was supported by a pilot grant from the Boston Nutrition and Obesity Research Center (NIH-NIDDK grant P30DK046200; to VP), an Evans Medical Foundation pilot grant (to VP), NIH-NIDDK R56DK094815 (to VP), R24 DK087669, DK08257 and 5U01ES020958-03 (to ASG) and grant 58-1950-7-707 from the USDA Agricultural Service (to ASG).
Abbreviations
- FSP27
Fat specific protein 27
- PLIN1
Perilipin 1
- TG
triglyceride
- aa
Amino acids
- LD
lipid droplet
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Walther TC, Farese RV., Jr Lipid droplets and cellular lipid metabolism. Annu Rev Biochem. 2012;81:687–714. doi: 10.1146/annurev-biochem-061009-102430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Farese RV, Jr, Walther TC. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell. 2009;139:855–60. doi: 10.1016/j.cell.2009.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wolins NE, Brasaemle DL, Bickel PE. A proposed model of fat packaging by exchangeable lipid droplet proteins. FEBS Lett. 2006;580:5484–91. doi: 10.1016/j.febslet.2006.08.040. [DOI] [PubMed] [Google Scholar]
- 4.Fujimoto T, Parton RG. Not just fat: the structure and function of the lipid droplet. Cold Spring Harb Perspect Biol. 2011;3 doi: 10.1101/cshperspect.a004838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Martin S, Parton RG. Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol. 2006;7:373–8. doi: 10.1038/nrm1912. [DOI] [PubMed] [Google Scholar]
- 6.Walther TC, Farese RV., Jr The life of lipid droplets. Biochim Biophys Acta. 2009;1791:459–66. doi: 10.1016/j.bbalip.2008.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Greenberg AS, Egan JJ, Wek SA, Garty NB, Blanchette-Mackie EJ, Londos C. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem. 1991;266:11341–6. [PubMed] [Google Scholar]
- 8.Greenberg AS, Coleman RA, Kraemer FB, McManaman JL, Obin MS, Puri V, Yan QW, Miyoshi H, Mashek DG. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest. 2011;121:2102–10. doi: 10.1172/JCI46069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Brasaemle DL. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res. 2007;48:2547–59. doi: 10.1194/jlr.R700014-JLR200. [DOI] [PubMed] [Google Scholar]
- 10.Ducharme NA, Bickel PE. Lipid droplets in lipogenesis and lipolysis. Endocrinology. 2008;149:942–9. doi: 10.1210/en.2007-1713. [DOI] [PubMed] [Google Scholar]
- 11.Kimmel AR, Brasaemle DL, McAndrews-Hill M, Sztalryd C, Londos C. Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular, lipid storage droplet proteins. J Lipid Res. 2009 doi: 10.1194/jlr.R000034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Londos C, Sztalryd C, Tansey JT, Kimmel AR. Role of PAT proteins in lipid metabolism. Biochimie. 2005;87:45–9. doi: 10.1016/j.biochi.2004.12.010. [DOI] [PubMed] [Google Scholar]
- 13.Londos C, Brasaemle DL, Gruia-Gray J, Servetnick DA, Schultz CJ, Levin DM, Kimmel AR. Perilipin: unique proteins associated with intracellular neutral lipid droplets in adipocytes and steroidogenic cells. Biochem Soc Trans. 1995;23:611–5. doi: 10.1042/bst0230611. [DOI] [PubMed] [Google Scholar]
- 14.Subramanian V, Rothenberg A, Gomez C, Cohen AW, Garcia A, Bhattacharyya S, Shapiro L, Dolios G, Wang R, Lisanti MP, Brasaemle DL. Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem. 2004;279:42062–71. doi: 10.1074/jbc.M407462200. [DOI] [PubMed] [Google Scholar]
- 15.Lass A, Zimmermann R, Haemmerle G, Riederer M, Schoiswohl G, Schweiger M, Kienesberger P, Strauss JG, Gorkiewicz G, Zechner R. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab. 2006;3:309–19. doi: 10.1016/j.cmet.2006.03.005. [DOI] [PubMed] [Google Scholar]
- 16.Granneman JG, Moore HP, Granneman RL, Greenberg AS, Obin MS, Zhu Z. Analysis of lipolytic protein trafficking and interactions in adipocytes. J Biol Chem. 2007;282:5726–35. doi: 10.1074/jbc.M610580200. [DOI] [PubMed] [Google Scholar]
- 17.Zechner R, Zimmermann R, Eichmann TO, Kohlwein SD, Haemmerle G, Lass A, Madeo F. FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 2012;15:279–91. doi: 10.1016/j.cmet.2011.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Granneman JG, Moore HP, Krishnamoorthy R, Rathod M. Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl) J Biol Chem. 2009;284:34538–44. doi: 10.1074/jbc.M109.068478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Miyoshi H, Perfield JW, 2nd, Souza SC, Shen WJ, Zhang HH, Stancheva ZS, Kraemer FB, Obin MS, Greenberg AS. Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes. J Biol Chem. 2007;282:996–1002. doi: 10.1074/jbc.M605770200. [DOI] [PubMed] [Google Scholar]
- 20.Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ, Gorenstein D, Chen KH, Chan L. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet. 2000;26:474–9. doi: 10.1038/82630. [DOI] [PubMed] [Google Scholar]
- 21.Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, Reitman ML, Deng CX, Li C, Kimmel AR, Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A. 2001;98:6494–9. doi: 10.1073/pnas.101042998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD, Moss LG, Greenberg AS. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem. 1998;273:24665–9. doi: 10.1074/jbc.273.38.24665. [DOI] [PubMed] [Google Scholar]
- 23.Gandotra S, Lim K, Girousse A, Saudek V, O’Rahilly S, Savage DB. Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5) J Biol Chem. 2011;286:34998–5006. doi: 10.1074/jbc.M111.278853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gandotra S, Le Dour C, Bottomley W, Cervera P, Giral P, Reznik Y, Charpentier G, Auclair M, Delepine M, Barroso I, Semple RK, Lathrop M, Lascols O, Capeau J, O’Rahilly S, Magre J, Savage DB, Vigouroux C. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med. 2011;364:740–8. doi: 10.1056/NEJMoa1007487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Puri V, Ranjit S, Konda S, Nicoloro SM, Straubhaar J, Chawla A, Chouinard M, Lin C, Burkart A, Corvera S, Perugini RA, Czech MP. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A. 2008;105:7833–8. doi: 10.1073/pnas.0802063105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Keller P, Petrie JT, De Rose P, Gerin I, Wright WS, Chiang SH, Nielsen AR, Fischer CP, Pedersen BK, MacDougald OA. Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem. 2008;283:14355–65. doi: 10.1074/jbc.M708323200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Puri V, Konda S, Ranjit S, Aouadi M, Chawla A, Chouinard M, Chakladar A, Czech MP. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem. 2007;282:34213–8. doi: 10.1074/jbc.M707404200. [DOI] [PubMed] [Google Scholar]
- 28.Kim JY, Liu K, Zhou S, Tillison K, Wu Y, Smas CM. Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death. Am J Physiol Endocrinol Metab. 2008;294:E654–67. doi: 10.1152/ajpendo.00104.2007. [DOI] [PubMed] [Google Scholar]
- 29.Jambunathan S, Yin J, Khan W, Tamori Y, Puri V. FSP27 Promotes Lipid Droplet Clustering and Then Fusion to Regulate Triglyceride Accumulation. PLoS One. 2011;6:e28614. doi: 10.1371/journal.pone.0028614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gong J, Sun Z, Wu L, Xu W, Schieber N, Xu D, Shui G, Yang H, Parton RG, Li P. Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites. J Cell Biol. 2011;195:953–63. doi: 10.1083/jcb.201104142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W, Inoue K, Kitazawa R, Kitazawa S, Matsuki Y, Hiramatsu R, Masubuchi S, Omachi A, Kimura K, Saito M, Amo T, Ohta S, Yamaguchi T, Osumi T, Cheng J, Fujimoto T, Nakao H, Nakao K, Aiba A, Okamura H, Fushiki T, Kasuga M. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest. 2008;118:2808–21. doi: 10.1172/JCI34090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Puri V, Czech MP. Lipid droplets: FSP27 knockout enhances their sizzle. J Clin Invest. 2008;118:2693–6. doi: 10.1172/JCI36554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK, Dash S, Hyden CS, Bottomley W, Vigouroux C, Magre J, Raymond-Barker P, Murgatroyd PR, Chawla A, Skepper JN, Chatterjee VK, Suliman S, Patch AM, Agarwal AK, Garg A, Barroso I, Cinti S, Czech MP, Argente J, O’Rahilly S, Savage DB. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med. 2009;1:280–7. doi: 10.1002/emmm.200900037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lee MJ, Wu Y, Fried SK. A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes. Obesity (Silver Spring) 2012;20:2334–40. doi: 10.1038/oby.2012.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mostoslavsky G, Kotton DN, Fabian AJ, Gray JT, Lee JS, Mulligan RC. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther. 2005;11:932–40. doi: 10.1016/j.ymthe.2005.01.005. [DOI] [PubMed] [Google Scholar]
- 36.Miyoshi H, Souza SC, Zhang HH, Strissel KJ, Christoffolete MA, Kovsan J, Rudich A, Kraemer FB, Bianco AC, Obin MS, Greenberg AS. Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J Biol Chem. 2006;281:15837–44. doi: 10.1074/jbc.M601097200. [DOI] [PubMed] [Google Scholar]
- 37.Nian Z, Sun Z, Yu L, Toh SY, Sang J, Li P. Fat-specific protein 27 undergoes ubiquitin-dependent degradation regulated by triacylglycerol synthesis and lipid droplet formation. J Biol Chem. 2010;285:9604–15. doi: 10.1074/jbc.M109.043786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Souza SC, Muliro KV, Liscum L, Lien P, Yamamoto MT, Schaffer JE, Dallal GE, Wang X, Kraemer FB, Obin M, Greenberg AS. Modulation of hormone-sensitive lipase and protein kinase A-mediated lipolysis by perilipin A in an adenoviral reconstituted system. J Biol Chem. 2002;277:8267–72. doi: 10.1074/jbc.M108329200. [DOI] [PubMed] [Google Scholar]
- 39.Yang X, Heckmann BL, Zhang X, Smas CM, Liu J. Distinct Mechanisms Regulate ATGL-Mediated Adipocyte Lipolysis by Lipid Droplet Coat Proteins. Mol Endocrinol. 2013;27:116–26. doi: 10.1210/me.2012-1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Li F, Gu Y, Dong W, Li H, Zhang L, Li N, Li W, Song Y, Jiang L, Ye J, Li Q. Cell death-inducing DFF45-like effector, a lipid droplet-associated protein, might be involved in the differentiation of human adipocytes. FEBS J. 2010;277:4173–83. doi: 10.1111/j.1742-4658.2010.07806.x. [DOI] [PubMed] [Google Scholar]
- 41.Bostrom P, Andersson L, Rutberg M, Perman J, Lidberg U, Johansson BR, Fernandez-Rodriguez J, Ericson J, Nilsson T, Boren J, Olofsson SO. SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity. Nat Cell Biol. 2007;9:1286–93. doi: 10.1038/ncb1648. [DOI] [PubMed] [Google Scholar]
- 42.Toh SY, Gong J, Du G, Li JZ, Yang S, Ye J, Yao H, Zhang Y, Xue B, Li Q, Yang H, Wen Z, Li P. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. PLoS One. 2008;3:e2890. doi: 10.1371/journal.pone.0002890. [DOI] [PMC free article] [PubMed] [Google Scholar]

